Literature DB >> 15236729

Palliative care for colorectal cancer.

Farin Amersi1, Michael J Stamos, Clifford Y Ko.   

Abstract

Most patients with stage IV colorectal cancer have a poor prognosis,but numerous palliative modalities are available today. When a cure is no longer possible, treatment is directed toward providing symptomatic relief. The data leave little doubt that surgical resection may provide good palliation. Although resection has been the mainstay of palliative care, an individualized multidisciplinary approach, which may involve both surgical and nonsurgical modalities, is probably the best current option.

Entities:  

Mesh:

Year:  2004        PMID: 15236729     DOI: 10.1016/j.soc.2004.03.002

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  3 in total

Review 1.  Management of stage IV rectal cancer: palliative options.

Authors:  Sean M Ronnekleiv-Kelly; Gregory D Kennedy
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

2.  Efficacy of ex vivo activated and expanded natural killer cells and T lymphocytes for colorectal cancer patients.

Authors:  Baskar Subramani; Chithra Ramanathan Pullai; Kohila Krishnan; Sheela Devi Sugadan; Xuewen Deng; Terunuma Hiroshi; Kananathan Ratnavelu
Journal:  Biomed Rep       Date:  2014-03-26

3.  Fecal microbiota in patients with a stoma decreases anaerobic bacteria and alters taxonomic and functional diversities.

Authors:  Shunsuke A Sakai; Masato Aoshima; Kentaro Sawada; Satoshi Horasawa; Ayumu Yoshikawa; Takao Fujisawa; Shigenori Kadowaki; Tadamichi Denda; Nobuhisa Matsuhashi; Hisateru Yasui; Masahiro Goto; Kentaro Yamazaki; Yoshito Komatsu; Ryota Nakanishi; Yoshiaki Nakamura; Hideaki Bando; Yamato Hamaya; Shun-Ichiro Kageyama; Takayuki Yoshino; Katsuya Tsuchihara; Riu Yamashita
Journal:  Front Cell Infect Microbiol       Date:  2022-09-14       Impact factor: 6.073

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.